Clinical Trials Browser

Phase 3 × Nasopharyngeal Neoplasms × Gemcitabine × Clear all

Nasopharyngeal Neoplasms

NCT07373990 2026-01-28

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase 3 Not yet recruiting

418 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT03924986 2025-01-31

RATIONALE-309

Phase 3 Completed

263 enrolled 19 charts

Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT05587374 2025-01-23

GEMSTONE

Phase 3 Active not recruiting

490 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT03840421 2025-01-13

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

468 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT02611960 2023-07-13

Keynote-122

Phase 3 Completed

233 enrolled 21 charts

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms

NCT00370890 2022-02-17

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Phase 3 Completed

104 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT01528618 2021-10-04

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Phase 3 Completed

362 enrolled

Head & Neck

Nasopharyngeal Neoplasms

Clinical Trials

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

RATIONALE-309

GEMSTONE

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Keynote-122

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma